OCT 15, 2020 8:04 PM PDT

WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections

WRITTEN BY: Carmen Leitch

While the study has not yet been peer-reviewed, an international consortium has come to the conclusion that the antiviral drug remdesivir has little or no benefit for hospitalized COVID-19 patients. The study followed 11,266 adult patients in 405 hospitals in thirty countries. Of this group, 2,750 were treated with remdesivir, 954 received hydroxychloroquine, others received a drug treatment used for HIV, and just over 4,000 others were not given any of these medications.

Colorized scanning electron micrograph of a cell showing morphological signs of apoptosis, infected with SARS-COV-2 virus particles (orange), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. / Credit: NIAID

The study assessed whether the drugs had any impact on mortality, when the patients needed ventilation, and the length of hospitalized patients' stays. In a statement, the World Health Organization (WHO) noted that the research did not assess whether any of these drugs have a preventive effect or might be useful for people that are not hospitalized.

This study confirms others that have indicated that hydroxychloroquinine has no beneficial effect.

Previous work has indicated that remdesivir can benefit patients that are on ventilators but not mild cases; in other words, the patient's condition has to be dire for remdesivir to work, according to other findings.

In a statement, the maker of remdesivir, GIlead, pushed back against WHO's data.

"The emerging data appear inconsistent with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of Veklury (remdesivir). We are concerned that the data from this open-label global trial have not undergone the rigorous review required to allow for constructive scientific discussion," Gilead said.

Earlier this year, the National Institutes of Health reported that a clinical trial involving patients hospitalized with COVID-19 and treated with remdesivir had shown positive results, but those benefits were modest. The trial suggested that patients on remdesivir would recover within around eleven days compared to fifteen days for people taking a placebo. The work also indicated that it may reduce mortality; 8.0 percent of people on remdesivir died, while 11.6 percent on placebo died. However, the trial was criticized for not including a diverse cohort of participants.

The NIH is currently conducting a study to investigate whether remdesivir plus interferon beta-1a is effective at treating COVID-19.

Sources: medRxiv, WHO, NIH

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 18, 2020
Genetics & Genomics
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
OCT 18, 2020
'Silent' Mutations Might Have Given SARS-CoV-2 an Edge
The pandemic virus SARS-CoV-2 is thought to have originated in bats, like many viruses. To make the leap and infect anot ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
NOV 14, 2020
Microbiology
The Structure of a Bacteriophage DNA Tube is Revealed
NOV 14, 2020
The Structure of a Bacteriophage DNA Tube is Revealed
Some viruses only infect bacteria; they care called bacteriophages or phages for short. As antibiotic-resistant bacteria ...
NOV 30, 2020
Plants & Animals
How to Help Plants Thrive While Reducing Fertilizer Use
NOV 30, 2020
How to Help Plants Thrive While Reducing Fertilizer Use
Soil helps provide plants with some of the nutrients they need, like phosphorous. Fertilizers may include phosphorous, w ...
DEC 06, 2020
Microbiology
Why is Foot-and-Mouth Disease so Infectious?
DEC 06, 2020
Why is Foot-and-Mouth Disease so Infectious?
There are two diseases with similar names: hand, foot, and mouth disease, which affects people, and foot-and-mouth disea ...
JAN 17, 2021
Microbiology
Gut Microbes May Play a Role in Anorexia
JAN 17, 2021
Gut Microbes May Play a Role in Anorexia
Eating disorders like anorexia nervosa and bulimia nervosa are illnesses that involve serious disturbances in eating beh ...
Loading Comments...